CDKN2A and glioblastoma: Limited changes were observed in the myeloid compartment in response to either RT + IT regimen (Fig. 3d and Extended Data Fig. 4b) aside from an increased neutrophil content specifically in RT + Conc.IT-treated PDG-Ink4a glioblastoma (Extended Data Fig. 4c).